NanoString
GenomeWeb Top 40 Up 11 Percent in November, Reversing String of Declines
The Dow Jones Industrial Average was up 9 percent, the Nasdaq was up 11 percent, and the Nasdaq Biotech Index was up 5 percent.
JP Morgan Downgrades NanoString Technologies to Neutral
The downgrade follows a Delaware jury's recent finding that NanoString's GeoMx Digital Spatial Profiler infringes seven patents held by 10x Genomics.
NanoString Shares Crater After 10x Genomics Wins $31M Verdict in Spatial Patent Suit
10x Genomics said it plans to seek a permanent injunction against the sales and use of GeoMx instruments and reagents in the US.
NanoString Technologies Books 63 Percent Revenue Growth in Q3 With Strong Spatial Instrument Sales
The Seattle-based company's Q3 spatial biology instrument revenues grew 350 percent year over year thanks to "accelerated" CosMx shipments.
A team led by researchers from Duke University used Xenium to help understand the molecular underpinnings of lethal pediatric brain tumors.